NewsMV
Frazier Life Sciences Acquisition Corp. II has completed its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share, raising a total of $75,000,000.
The special purpose acquisition company, listed on The Nasdaq Capital Market under the ticker symbol FLSC, began trading on October 14, 2026.
The Palo Alto-based entity was formed to execute a business combination, such as a merger, asset purchase, or reorganization, with one or more other entities.
While the company may pursue opportunities in any industry or geographical location, it intends to leverage its management team's experience to identify promising targets within the biotechnology sector.
Keep reading